Endowed Professor of Nursing Innovation and Leadership
The Center for Infectious Disease and Nursing Innovation, Johns Hopkins
Middle River, MD, United States
I am an Endowed Professor of Nursing Innovation and Leadership at The Johns Hopkins University School of Nursing where I direct The Center for Infectious Disease and Nursing Innovation. As an Infectious Disease Epidemiologist and a board-certified primary care Adult Nurse Practitioner, my two decades of clinical practice spans HIV clinical care, prevention, and the management of associated opportunistic infections. My program of research seeks to optimize a patient’s movement along the care cascade, from the initial diagnostic experience, health system navigation and linkage to care, as well as retention in care. I operationalize this work through the design of multi-component interventions that seek to build an equitable care experience that is adaptable to the individual’s need. I recently led a cluster randomized trial [R01AI104488] designed to tailor nurse case management for persons with drug-resistant Tuberculosis and HIV co-infection and I am a co-investigator on an adaptive, SMART trial [R01 NR016650], which involves an adaptive randomized evaluation of nurse-led HIV treatment and retention interventions for female sex workers living with HIV, both in South Africa. I am currently leading a feasibility and acceptability pilot randomized trial in rural South Africa to test whether video directly observed therapy coupled with an escalating adherence support model utilizing community health worker will improve RR-TB/HIV treatment adherence. This application builds upon this exceptionally strong foundation of prior work in South Africa coupled with substantial preliminary evidence of nurse-led models of care. These preliminary works include an evaluation of clinical outcomes through a prospective cohort study funded by the National Department of Health and capacity building program funded by the Global Fund for AIDS, TB and Malaria as well as the Centers for Disease Control and Prevention. I also have experience leading MPI studies. Presently I serve as a MPI on a RADxUp Initiative funded comparative effectiveness three-arm trial to evaluate COVID-19 testing modalities in Baltimore City. My experience in leading large, multi-site clinical trials is demonstrated by leadership of our HIV Prevention Trials Network (HPTN) within the Clinical Trials Unit of the Johns Hopkins AIDS Clinical Trials Group, which now includes serving as PI of all of the Coronavirus Prevention Network (CoVPN) studies. I am the clinical core, co-director of our Center for AIDS Research and the Development Core, Co-Director of the TB Research Advancement Center.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thursday, October 20, 2022
8:00 AM – 9:00 AM US ET
Thursday, October 20, 2022
8:00 AM – 8:30 AM US ET